Profil
John Peter Stefano Holden is the founder of Tinderbox Working Capital Ltd., which was founded in 2013.
He held the title of Chief Executive Officer at Tinderbox Working Capital Ltd. Mr. Holden's current job is as a Director at Foresight Group LLP, starting in 2016.
Mr. Holden's former jobs include being a Director-Ventures Development at ANGLE Plc, an Investment Director at Touchstone Innovations Ltd. from 2007 to 2012, a Non-Executive Director at OSspray Ltd., an Investment Director at Veryan Medical Ltd., a Non-Executive Director at RepRegen Ltd. from 2012 to 2013, a Director at Cortexica Vision Systems Ltd., a Director at Veryan Holdings Ltd. from 2008 to 2012, a Director at Technology Group Ltd., a Principal at Hoare Govett Ltd., and a Principal at 3i Venture Capital.
Mr. Holden's education includes an MBA from Cranfield University and an undergraduate degree from the University of Durham.
Postes actifs de John Peter Stefano Holden
| Sociétés | Poste | Début |
|---|---|---|
Foresight Group LLP
Foresight Group LLP Investment ManagersFinance Foresight Group invests in companies located in the United Kingdom and Ireland. The firm focuses across a broad range of sectors and industries. It provides financing in the form of equity and debt for seed, early, growth, and buyout transactions with an investment size ranging from GBP 2 - 50 million. | Private Equity Investor | 01/11/2016 |
Anciens postes connus de John Peter Stefano Holden
| Sociétés | Poste | Fin |
|---|---|---|
OSspray Ltd.
OSspray Ltd. Chemicals: Major DiversifiedProcess Industries Provides bioactive powders for teeth cutting, cleaning and whitening | Directeur/Membre du Conseil | 03/01/2014 |
RepRegen Ltd.
RepRegen Ltd. Medical/Nursing ServicesHealth Services Develops synthetic, biologically-active and tissue engineering products | Directeur/Membre du Conseil | 07/03/2013 |
Veryan Holdings Ltd.
Veryan Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a holding company which provides research and development services for clinical trails of novel vascular devices | Directeur/Membre du Conseil | 09/11/2012 |
Tinderbox Working Capital Ltd.
Tinderbox Working Capital Ltd. Financial ConglomeratesFinance Provides working capital finance | Directeur Général | - |
3i Venture Capital
3i Venture Capital Investment ManagersFinance 3i VC is an active manager which works as a global team to select approximately twenty early- to late-stage investments per year. They aim to invest in companies with exceptional leadership, entrepreneurial flair, proven technical and business expertise, innovative technology and the vision to create a new market or gain significant share of an existing market. The firm prefers to lead or co-lead investments, and selects opportunities where they can create and realize significant value, take board seats and achieve exits via trade sales or IPOs. They target the healthcare, communications, software and ESAT (electronics, semiconductors and advanced technologies) sectors in Europe, the US and Asia. They invest in a series of funding rounds, separating 'first investments' (in businesses where 3i is not already invested) and 'further investments'. 3i VC actively supports their investee companies, making introductions and offering strategic guidance to accelerate their success. The majority of the firm's venture capital investment is made directly from 3i's balance sheet. | Corporate Officer/Principal | - |
Formation de John Peter Stefano Holden
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
CelLBxHealth Plc
CelLBxHealth Plc Medical DistributorsDistribution Services Operates as a holding company with interests in providing products in cancer diagnostics and foetal health | Distribution Services |
Touchstone Innovations Ltd.
Touchstone Innovations Ltd. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Foresight Group LLP
Foresight Group LLP Investment ManagersFinance Foresight Group invests in companies located in the United Kingdom and Ireland. The firm focuses across a broad range of sectors and industries. It provides financing in the form of equity and debt for seed, early, growth, and buyout transactions with an investment size ranging from GBP 2 - 50 million. | Finance |
Hoare Govett Ltd.
Hoare Govett Ltd. Investment ManagersFinance Provides financial advice service | Finance |
Cranfield University
Cranfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Durham
University of Durham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
3i Venture Capital
3i Venture Capital Investment ManagersFinance 3i VC is an active manager which works as a global team to select approximately twenty early- to late-stage investments per year. They aim to invest in companies with exceptional leadership, entrepreneurial flair, proven technical and business expertise, innovative technology and the vision to create a new market or gain significant share of an existing market. The firm prefers to lead or co-lead investments, and selects opportunities where they can create and realize significant value, take board seats and achieve exits via trade sales or IPOs. They target the healthcare, communications, software and ESAT (electronics, semiconductors and advanced technologies) sectors in Europe, the US and Asia. They invest in a series of funding rounds, separating 'first investments' (in businesses where 3i is not already invested) and 'further investments'. 3i VC actively supports their investee companies, making introductions and offering strategic guidance to accelerate their success. The majority of the firm's venture capital investment is made directly from 3i's balance sheet. | Finance |
OSspray Ltd.
OSspray Ltd. Chemicals: Major DiversifiedProcess Industries Provides bioactive powders for teeth cutting, cleaning and whitening | Process Industries |
Veryan Medical Ltd.
Veryan Medical Ltd. BiotechnologyHealth Technology Develops and commercializes novel vascular stent technology | Health Technology |
RepRegen Ltd.
RepRegen Ltd. Medical/Nursing ServicesHealth Services Develops synthetic, biologically-active and tissue engineering products | Health Services |
Cortexica Vision Systems Ltd.
Cortexica Vision Systems Ltd. Packaged SoftwareTechnology Services Develops image recognition and visual search technology | Technology Services |
Veryan Holdings Ltd.
Veryan Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a holding company which provides research and development services for clinical trails of novel vascular devices | Commercial Services |
Technology Group Ltd. | |
Tinderbox Working Capital Ltd.
Tinderbox Working Capital Ltd. Financial ConglomeratesFinance Provides working capital finance | Finance |
















